Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.
暂无分享,去创建一个
Mauro Ferrari | James M Tour | Xuewu Liu | Paolo Decuzzi | Mark Ming-Cheng Cheng | Ennio Tasciotti | M. Ferrari | P. Decuzzi | J. Tour | F. Robertson | E. Tasciotti | Xuewu Liu | B. K. Price | M. Cheng | R. Bhavane | K. Plant | A. Leonard | Rohan Bhavane | B Katherine Price | Ashley D Leonard | Fredika Robertson | Kevin Plant
[1] V. Lehto,et al. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[2] S. Kennel,et al. Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[3] A. Gabizon,et al. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. , 1991, Biochimica et biophysica acta.
[4] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[5] William C Eckelman,et al. Targeting proteins in vivo: in vitro guidelines. , 2006, Nuclear medicine and biology.
[6] H. Dai,et al. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] S. C. Bayliss,et al. The Culture of Mammalian Cells on Nanostructured Silicon , 1999 .
[8] Robert Langer,et al. Nanoparticle–aptamer bioconjugates for cancer targeting , 2006, Expert opinion on drug delivery.
[9] Mauro Ferrari,et al. Antibiological barrier nanovector technology for cancer applications , 2007, Expert opinion on drug delivery.
[10] M. Ferrari. Nanovector therapeutics. , 2005, Current opinion in chemical biology.
[11] Michael J. Sailor,et al. Compatibility of Primary Hepatocytes with Oxidized Nanoporous Silicon , 2001 .
[12] P Bongrand,et al. Diffusion of microspheres in shear flow near a wall: use to measure binding rates between attached molecules. , 2001, Biophysical journal.
[13] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[14] Peter W. Swaan,et al. Microfabricated Porous Silicon Particles Enhance Paracellular Delivery of Insulin Across Intestinal Caco-2 Cell Monolayers , 2004, Pharmaceutical Research.
[15] Michael J. Sailor,et al. Chemical Modification of Crystalline Porous Silicon Surfaces , 1999 .
[16] M Ferrari,et al. The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.
[17] K. Kairemo,et al. Targeted liposomal drug delivery in cancer. , 2004, Current pharmaceutical design.
[18] R. Stafford,et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] Mauro Ferrari,et al. Fantastic VoyagesNanodevices in Development Today Promise to Give Medicine Capabilities that Were Once Purely in the Realm of Fiction , 2006 .
[20] Yuchun Wang,et al. Surface modification of micromachined silicon filters , 2000 .
[21] M. Ferrari,et al. A Theoretical Model for the Margination of Particles within Blood Vessels , 2005, Annals of Biomedical Engineering.
[22] Michael J Sailor,et al. Delivery of nanogram payloads using magnetic porous silicon microcarriers. , 2006, Lab on a chip.
[23] L. Canham. Bioactive silicon structure fabrication through nanoetching techniques , 1995 .
[24] M. Teitell,et al. The evolution of antibodies into versatile tumor-targeting agents. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] L. Canham,et al. Derivatized Mesoporous Silicon with Dramatically Improved Stability in Simulated Human Blood Plasma , 1999 .
[26] J. Buriak,et al. Chemical and Biological Applications of Porous Silicon Technology , 2000 .
[27] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[28] Vladimir P Torchilin,et al. Multifunctional nanocarriers. , 2006, Advanced drug delivery reviews.
[29] A. Alavi,et al. Opportunities and Challenges , 1998, In Vitro Diagnostic Industry in China.
[30] T. Mihaljevic,et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.
[31] Shuming Nie,et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.
[32] Mauro Ferrari,et al. Adhesion of Microfabricated Particles on Vascular Endothelium: A Parametric Analysis , 2004, Annals of Biomedical Engineering.
[33] Jennifer Sturgis,et al. Bacteria-mediated delivery of nanoparticles and cargo into cells. , 2007, Nature nanotechnology.